Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
about
Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling.Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsA mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy.A data-driven model of biomarker changes in sporadic Alzheimer's disease.Determinants of vascular dementia in the Cardiovascular Health Cognition Study.Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Temporally Constrained Group Sparse Learning for Longitudinal Data Analysis in Alzheimer's Disease.Quantitative T1 and T2 MRI signal characteristics in the human brain: different patterns of MR contrasts in normal ageingStructural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study.Improving data availability for brain image biobanking in healthy subjects: Practice-based suggestions from an international multidisciplinary working group.Parallel imaging: is GRAPPA a useful acquisition tool for MR imaging intended for volumetric brain analysis?Comparison of phantom and registration scaling corrections using the ADNI cohort.Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease.White matter damage in maintenance hemodialysis patients: a diffusion tensor imaging study.Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.Serial MRI and CSF biomarkers in normal aging, MCI, and ADA novel matrix-similarity based loss function for joint regression and classification in AD diagnosisPredicting progression of Alzheimer's disease using ordinal regression.An efficient approach for differentiating Alzheimer's disease from normal elderly based on multicenter MRI using gray-level invariant features.Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustmentPrediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classificationPredicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers.Efficient Blockwise Permutation Tests Preserving ExchangeabilityPrenatal cocaine effects on brain structure in early infancyAPP as a Protective Factor in Acute Neuronal Insults.Multimodal classification of Alzheimer's disease and mild cognitive impairment.Weighted brain networks in disease: centrality and entropy in human immunodeficiency virus and agingInvestigating the genetics of hippocampal volume in older adults without dementia.Variance in brain volume with advancing age: implications for defining the limits of normality.Alzheimer's disease, anesthesia and the cholinergic system.Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease.Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.A practical guideline for intracranial volume estimation in patients with Alzheimer's disease.Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's diseaseUse of brain MRI atlases to determine boundaries of age-related pathology: the importance of statistical method.Inclusion of Neuropsychological Scores in Atrophy Models Improves Diagnostic Classification of Alzheimer's Disease and Mild Cognitive ImpairmentWays toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).Epitope Fingerprinting for Recognition of the Polyclonal Serum Autoantibodies of Alzheimer's Disease.Left hippocampus-amygdala complex macro- and microstructural variation is associated with BDNF plasma levels in healthy elderly individuals.Exercise Mode Moderates the Relationship Between Mobility and Basal Ganglia Volume in Healthy Older Adults
P2860
Q27339937-B5D5651D-254C-4D75-8DAD-B0E5BD3B6DC1Q28488143-613F9590-49DD-4394-865B-5F2C64D6EB60Q30585565-56E2316C-E33C-453A-8A83-49E89E5E7286Q30835966-EC52A167-F4C2-4861-975E-8480D02AF838Q30989421-E3F7503D-F720-4D59-A8B4-2454D444E1DDQ31050728-1EBBD1C3-F990-4FEA-9E8F-22EB6B8DE486Q31080794-348E5E05-C208-4DFD-B407-76B567DA10FFQ31110099-7E9BBC87-A1C1-43C0-8FD4-49DF071BD8D2Q31152078-804B7541-7743-4E27-B01B-39A6B836EC7AQ31165329-B293815A-647D-4E6F-BB0F-1BEBEFCC312BQ33489842-E9B365C6-430C-4C0C-8C73-804B98D445B3Q33565800-9DB342A6-AD18-41E2-A052-7C3EC72EE3D0Q33721825-628569FB-849C-4D4F-8F84-18B33A825A14Q33872095-345A2D22-0FBF-4FBC-BD29-FC3B06700C58Q33990663-86EE74CB-3B2B-4AB1-946F-2FD817AA9666Q34002953-B0987D4C-55B2-47DC-82D3-5CD3ACDEDC63Q34066974-883C5C2F-656D-4114-9581-951091970343Q34070810-D2A55BB6-2265-4A37-AEFD-FFCD6A81C35DQ34070840-4FEEEC90-729F-46FB-9844-A117C766FAAFQ34163448-19EEFA1D-D833-4971-A940-9C062DEA35C9Q34183016-F9F85B18-AD96-4612-A20F-DEB865365C52Q34211760-40CB61FF-A09E-4C8E-8034-68078BE9E31EQ34289148-F5897843-C3F2-418B-A55E-1AD794C4F5A0Q34470996-89C35EDE-C0E0-4CE3-8949-0C62E8EF1011Q34551487-CD7654B4-937E-4FF6-A33E-1CCC95CBA7C2Q34672813-F4E5500F-6760-4BAD-875E-E102424A6CA3Q34716695-06B4312A-A331-48CB-84ED-AD5EEF9D254EQ35019172-A8215B23-640B-4CAC-BB8F-489E3F6C8403Q35075666-6F5348F4-914A-4DD1-AD88-B84BF263F036Q35079720-1CE5DDBA-F349-4DB8-AFF6-55968E90E552Q35226739-03C6ADC8-1C97-41BC-93CE-8B2AD4A58D62Q35498087-527C71E7-A3E8-4081-8056-9CC8D3AA0C79Q35580510-22844FCD-17A9-4E18-809F-A72E236FF033Q35592787-B9C4E0E2-504E-4AFD-B636-6572C3D3D32DQ35646028-5488E286-F551-4AFA-B883-801B569A0A10Q35691484-574A67C5-0C4D-4FC9-A527-DEA268E90FD0Q35781558-C1046752-C3CE-4DA8-A10E-D918FF2DB6CFQ35791399-51199413-312F-4CA5-B3DC-058D0B29A89EQ35879259-ED522E80-CCD3-4E69-B308-09B57AC34C5DQ35897336-056FBF75-4AEB-4257-8543-FA81DE1B0AB7
P2860
Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
@en
type
label
Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
@en
prefLabel
Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
@en
P1433
P1476
Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
@en
P2093
Jonathan M Schott
P304
P356
10.1016/S0140-6736(04)15441-X
P407
P50
P577
2004-01-01T00:00:00Z